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Introduction.Theobjectiveofthisworkwastodefinethefrequencyandseverityofsteroidrelatedbehavioralsideeffectsinchildren
with steroid sensitive idiopathic nephrotic syndrome (SSNS) during Treatment for relapse. Methods.3 0p e d i a t r i cp a t i e n t sw i t h
steroid sensitive nephrotic syndrome were studied; known as SSNS at complete remission or low dose of Prednisolone and have
relapse on follow up. All children in this study were subjected to full history taking, thorough clinical examination, assessment
socioeconomic standard, and assessment of pediatric quality of life, a battery of psychometric tests included pediatric anxiety,
depression, and aggression scores. Results. Our results revealed that there are highly significant increase in the mean values of
anxiety, depression and aggression among cases starts to appear on week one and extends to three, five and seven weeks compared
to baseline. In the seventh week of follow up cases showsignificant positivecorrelation between prednisonedoses and mean values
of anxiety and depression scores and aggression. Conclusion. we concluded that all studied children with SSNS often experience
significant problems with anxiety, depression, and increased aggression during high dose steroid therapy.
1. Introduction
Since Edward Kendall isolated cortisone in the late 1930
and Philip Hench first used it to treat rheumatoid arthritis
in 1948. Corticosteroids have become the corner stone of
therapy for many neurologic, respiratory, gastrointestinal,
renal, endocrine, hematologic, neoplastic, rheumatologic,
dermatologic,ophthalmic,andallergicconditions.Morethan
10 million new corticosteroid prescriptions are filled each
year, up to 0.9% of the general population and as many as 7%
of hospitalized patients receiving oral corticosteroid therapy
at any given point [1].
Although a powerful therapeutic option, corticosteroids
a r ea s s o c i a t e dw i t hs e r i o u sa d v e r s ee ff e c t s ,b o t hp h y s i o -
logic and psychiatric. While the somatic adverse effects
of corticosteroid therapy have been extensively researched
and widely described, the neuropsychiatric adverse effects
have received less attention. Moreover, the etiology and
pathogenesisofthesebraineffectsremainpoorlyunderstood
The neuropsychiatric adverse effects of corticosteroids are
complex, unpredictable, and often severe, ranging across
most categories of psychopathology Mood liability, anxiety
symptoms, cognitive impairments, behavioral disturbances,
orpsychoticfeaturescanpresentaloneorincombination[2].
The aim of this study is to evaluate the psychosocial
aspects of Corticosteroids in children with nephrotic syn-
drome to define the frequency and severity of steroid-related
behavioral side effects in children with steroid-Sensitive
nephrotic syndrome (SSNS) during treatment for relapse in
comparison with those children in complete remission.
2. Subjects
We conducted a prospective, repeated-measure cross over
study, in which (30) children with SSNS underwent behav-
ioral assessment, with similar social level, and duration of
disease matched with the participants. Using the anxiety,
depression and aggression scales of children at baseline and2 ISRN Psychiatry
during high dose prednisone therapy for relapse, as follow;
1st assessment a baseline measure of the child’s behavior
will be done at a time when the child is in remission, off
prednisone, or on low dose—alternative day therapy (not
>0.5mg/kg every 48 hours), 2nd assessment At the initiation
of daily prednisone for relapse (2mg/kg/day), assess the
child’s behavior, 3rd, 4th, 5th, and 6th assessments repeated
every 2 weeks, that is, during weeks 1, 3, 5, and 7 of therapy
for relapse respectively.
This research was conducted from pediatric nephrology
unit,childrenhospital,ZagazigUniversity.Informedconsent
was taken from parents of each patient; the study was
approved by our ethical committee.
3. Methods
Inclusion Criteria. Patients between 6 years and 16 years, we
choose this age group to be cooperative during research,
Nephrotic patients (steroid sensitive) with matched duration
of disease and on corticosteroid therapy.
Exclusion Criteria. Patients with renal impairment (high
serum creatinine level), Patients with secondary nephrotic
syndrome, Diabetic patients, Patients on chemotherapy or
any drugs affecting behavior and psychiatric or neurological
disease.
All studied patients were subjected to the following:
Detailed history taking laying stress on; Age and sex, Sym-
ptoms of nephrotic syndrome, duration of the disease,
Response to steroid therapy, frequency of relapses, other
medications (Antihypertensive, antiplatelet), complications
of steroid therapy, behavior change and Thromboembolic
diseases.
Careful clinical examination was taken with stress on;
General examination weight, height, surface area and blood
pressure, Manifestations of nephrotic syndrome (puffy eye
lids, lower limb edema, ascites), manifestation of steroid side
effects.
Laboratory investigations including; Routine investiga-
tions for nephrotic syndrome including, Proteinuria by 24
hours urine collection, Serum albumin, total protein, Kidney
function test.
Psychological Assessment Using. At baseline and during
relapse, children completed the questionnaire about Anxi-
ety, depression and aggression, using children manifest the
anxiety Scale (CMAS)/children depression scale (CDI) and
Aggression scales of Children.
(A) Children Depression Inventory (CDI). The CDI depres-
sion test for pediatrics was filled by all the patients in a
standardized format the degree of depression among the
children who exposed to depressive condition in last two
weeks. The questionnaire consists of 27 statements self-rated
survey designed to assess cognitive, behavior and neuro-
vegatative signs of depression in children.
The Score of the Test. The instruction for the standard version
asks how much a problem each item has been during the
last two weeks. A 3 point response scale is used (0 = never
aproblem,1=oftenaproblem,2=almostalwaysaproblem).
Scoring.Bysummationoftheresults,scoringrangedfrom(0–
54) [3]:
(i) 0–9 indicates normal (minimal) depressive status.
(ii) 9–14 indicates mild depressive status for male.
(iii) 9–16 indicates mild depressive status for female.
(iv) 14–18 indicates moderate depressive status for male.
(v) 16–22indicatesmoderatedepressivestatusforfemale.
(vi) >18 indicate sever depressive status for male.
(vii) >22 indicate sever depressive status for female.
(B) Children Anxiety Scale. Children anxiety scale was filled
by all the patients. This scale was developed by Castaneda et
al. [4]. It consists of 53 items and each item consists of one
statement which has two answers yes or no.
(i) If the answer is (Yes) the degree = 1
(ii) If the answer is (No) the degree = zero
Total score ranges from (0–53) According to their scores,
they were classified into mild, moderate and severe degrees
[4].
(i) Mild anxiety is less than 18
(ii) Moderate anxiety is from 19–28
(iii) Severe anxiety is more than 29
(C)AggressionQuestionnaire(AQ).TheAggressionscalecon-
sistsof3factors,PhysicalAggression(PA),VerbalAggression
(VA), and Hostility (H). The total score for Aggression is the
sum of the factor scores.
Using the 4 point scale, indicate how uncharacteristic or
characteristiceachofthefollowingstatementsisindescribing
patient.
0 = extremely uncharacteristic of me
1 = somewhat uncharacteristic of me
2 = somewhat characteristic of me
3 = extremely characteristic of me
According to their scores, they were classified into low,
moderate and high degrees. AQ Score ranges are [5]:
None: 0–28T
Low: ≤29T–39T
Moderate: 40T–59T
High: 60T: ≥70T.
Statistical Analysis. Analysis of data was done by using SPSS
(statisticalprogramforsocialscienceversion12.Quantitative
variables were described as mean, SD and range. Qualitative
variables were described as number and percentage. Corre-
lation test was used to rank different variables against each
o th e rpo s i ti v e l yo ri n v e r se l y .𝑃value > 0.05 was insignificant,
𝑃 < 0.05 was significant and 𝑃 < 0.01 was highly significant.ISRN Psychiatry 3
Table 1: Mean values of scores of anxiety, depression and aggression of cases from baseline to 7th week of follow up.
Cases (𝑁=3 0 ) Baseline data Time/weeks
Test of significance 𝑃
One Three Five Seven
Anxiety
𝑋±SD
a 16.2 ± 6.2 25.6 ± 7.0
∗∗∗ 27.9 ± 7.5
∗∗∗ 26.6 ± 5.5
∗∗∗ 22.7 ± 5.4
∗∗∗
8.27 0.000
∗∗∗
Range 5.0–28.0 14.0–41.0 2.0–42.0 10.0–40.0 8.0–38.0
Depression
𝑋±SD
a 39.9 ± 7.4 46.5 ± 8.3
∗∗∗ 51.1 ± 7.4
∗∗∗ 48.4 ± 7.9
∗∗∗ 44.9 ± 7.6
∗∗∗
10.1 0.000
∗∗∗
Range 31.0–60.0 38.0–68.0 37.0–70.0 35.0–67.0 33.0–63.0
Aggression
𝑋±SD
a 30.1 ± 15.7 44.9 ± 14.7
∗∗∗ 48.5 ± 12.7
∗∗∗ 44.8 ± 11.2
∗∗∗ 37.5 ± 7.7
∗∗
84.8 0.000
∗∗∗
Range 0.0–49.8 0.0–67.5 0.0–69.7 0.0–59.0 0.0–45.6
a
Paired 𝑡-test: in comparison to base line. ∗∗∗𝑃 < 0.001,∗∗𝑃 < 0.01.
4. Results
In this study the distribution of anxiety score grades in
studied children showed
(i) 22 patients were low, 8 patients were moderate grade
at baseline.
(ii) 5 patients were low, 15 patients were moderate and 10
patients were high grade in 1st wk.
(iii) 1 patient was low, 11 patients were moderate and 18
patients were high grade in 3rd wk.
(iv) 1 patient was low, 19 patients were moderate and 10
patients were high grade in 5th wk.
(v) 3 patients were low, 24 patients were moderate and 3
patients were high grade in 7th wk.
Also in this study the distribution of CDI score grades in
studied children showed
(i) 2 patientswere mildgrade depression and28 patients
were normal grade at baseline.
(ii) 8 patients were mild grade depression, 2 patients
weremoderategradedepression,and20patientswere
normal grade at 1st wk.
(iii) 15 patients were mild grade depression, 2 patients
were moderate grade depression, 1 patient was severe
and 12 patients were normal grade at 3rd wk.
(iv) 11 patients were mild grade depression, 2 patients
were moderate grade depression and 17 patients were
normal grade at 5th wk.
(v) 7 patients were mild grade depression, 1 patient was
moderate grade depression and 22 patients were
normal grade at 7th wk.
Alsointhepresentstudyitwasfoundthatdistributionof
aggression score grades in studied children showed
(i) 20 patients were low grade, 4 patients were moderate
grade and 6 patients were normal grade at baseline.
(ii) 5 patients were low grade, 19 patients were moderate
grade, 4 patients were high grade and 2 patients were
normal grade at 1st wk.
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Figure 1: Statistical correlation of mean values of anxiety scores
among cases and prednisone doses mean during seven weeks of
follow-up.
(iii) 7 patients were low grade, 15 patients were moderate
grade, 7 patients were high grade and 1 patient was
normal grade at 3rd wk.
(iv) 7 patients were low grade, 22 patients were moderate
grade and 1 patient was normal grade at 5th wk.
(v) 23 patients were low grade, 6 patients were moderate
grade and 1 patient was normal grade at 5th wk.
Our results revealed that there are highly significant
increase in the mean values of anxiety, depression and
aggression among cases starts to appear on week one and
extends to three, five and seven weeks compared to baseline
Tables 1 and 2.
The seven weeks of follow up among cases show signifi-
cantpositivecorrelationbetweenprednisonedosesandmean
values of anxiety and depression scores and aggression (𝑃<
0.05)i nF i g u r e s1, 2,a n d3.
5. Discussion
Mostoften,patientsreceivingshort-termcorticosteroidther-
apy present with euphoria or hypomania, whereas long term
therapy tends to engender depressive symptoms [6].
Much like adults, children receiving corticosteroid ther-
apy have exhibited elevated levels of depression and anxiety,
as well as increases in insomnia, tearfulness, irritability,4 ISRN Psychiatry
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Figure 2: Statistical correlation of mean values of aggression scores
among cases and prednisone doses mean during seven weeks of
follow-up.
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Figure 3: Statistical correlation of mean values of depression scores
among cases and prednisone doses mean during seven weeks of
follow-up.
argumentativeness, fatigue, aggression, and inattentiveness
[7].
The present study enrolled 30 cases with SSNS. Their
ages ranged between 6–16 years with mean age of 9.9 ±
2.1 years. Those patients were selected from specialized
outpatient clinics and admitted patients in children hospital
ofZagazigUniversityHospital.Allchildreninthisstudywere
subjected to Psychological distress, the patients were asked
to fill in an Anxiety, Depression Scale (CDI) and aggression
questionnaire.
Inthepresentstudyitwasfoundthatwerehighstatistical
significantdifferencesduringsevenweeksoffollowupamong
casesindifferentgradesofanxiety,depressionandaggression
s c o r e sa sI tw a sf o u n d ,t h a tm e a nv a l u e so fs c o r e so fa n x i e t y ,
depression and aggression of cases from baseline to 7th wk
follow up were highly significant among cases Started to
appearonweekoneandextendstothree,fiveandsevenweeks
compared to baseline and control.
In accordance with our study Soliday et al., 1999 [8],
who reported that on behavioral effects of corticosteroids
in steroid-sensitive nephrotic syndrome; there is statistical
significance for marked increases in behavior problems dur-
ing relapse? On high dose prednisone, children studied had
CBCL scores for anxiety, depression, and aggressive behavior
above the 95th percentile for age.
Also Hall et al. 2003 [7] reported a significant increase in
total behavior score, specifically for aggressive behavior and
poor attention, in 12 children who received steroid treatment
for INS.
I no u rs t u d yw ef o u n d ,M e a nv a l u eo fp r e d n i s o n ed o s e
among cases at baseline is 0.25mg/kg/AD, while at first week
andthirdweekare2mg/kg/D,fifthweekis1.7mg/kg/ADand
lastly during seventh week is 1.4mg/kg/AD.
Ourstudy showeddifferenceinthedistributionofgrades
of scores of behavior in comparison with different doses of
prednisolone within seven weeks of follow up as
(i) In patients whom received dose of prednisolone
up to 0.5mg/kg/AD 66.6% low, 13.3% moderate of
aggression grade, 70% low, 30% moderate of anxiety
grade and 90% normal and 10% mild of depression
grade.
( i i )A t1 s tw ka n d3 r dw kp a t i e n tr e c e i v e dd a i l yd o s e so f
prednisolone up to 2.0mg/kg/D showed increase in
mean value of behavior score grade CDI, anxiety and
aggressionfrommild/lowtomoderateandhighscore
especially anxiety and aggression score.
(iii) At 5th wk and 7th wk patient whom received alterna-
tive daily doses of prednisolone up to 1.5mg/kg/AD
s h o w e ds t i l lh i g ho re l e v a t e dm e a nv a l u eo fb e h a v -
i o rs c o r eg r a d ei nr e l a t i o nt ob a s e l i n es c o r e sb u t
patients showed decrease in high and severe scores
and increase moderate score grades among patients
in relation to 1st and 3rd wk.
Also in our study we tried to find a correlation between
anxiety, CDI score; aggression scores and prednisone doses
which showed significant positive correlation between pred-
nisone doses and mean values of anxiety, CDI; aggression
scores (𝑃 < 0.05).
In accordance with our study Mishra et al. [9]f o u n d
abnormalities in all behavioral scales having close correla-
tionswiththecumulativedoseofprednisoloneadministered.
These findings are in line with previous observations identi-
fying prednisolone dose as a strong predictor of behavioral
abnormalities, especially increased aggressive behavior.
It is agreeing with Waber et al. [10]W h or e p o r t e di th a s
been repeatedly that steroid effects are dose related.
Bender et al., 1991 [11] Studied in children with asthma
and cancer, however, suggested that steroids have a potential
adverse effect on children’s behavior, although such studies
have been complicated by many of the children being on
multiple drugs.
To overcome this problem Soliday et al. [8]s t u d i e d
nephrotic children in relapse, taking the baseline assessment
at a time of remission. This, however, introduces the problem
that all of their children would, therefore, have received at
least one course of steroids prior to the study. It has been
suggested that there was an effect from repeated courses of
steroids causing sensitization and increasing the occurrence
of abnormal behavior.
Itisinaccordancewithourstudybeingassesschildrenfor
first time as base line for behavior on complete remission or6 ISRN Psychiatry
minimal dose of prednisolone till relapse occurred and high
prednisolone dose used according to standard regimen.
It is disagreeing with our study where in previous studies
hadbeenusedchildbehaviorchicklist(CBCL)withsubscale
for anxiety, depression and aggression scores and children
wereassessedbytheirparentsandteacherswhileinourstudy
patients were assessed by themselves, In order to further
explore the impact of these additional psychological factors,
itwouldhavebeenofinteresttoincludepatientself-reporting
by schoolchildren and objective behavioral assessments by
independent third observers such as teachers and compare
their perspectives with that of the parents.
In this study we found that there were no statistical
significance differences On fifth and seventh weeks of follow
up between scores of anxiety, depression; aggression and
prednisolone dose values using Fisher Exact and 𝑃 value
(>0.05).
In this study we found that there were no statistical
significance differences as regard baseline scores of anxiety,
depression and aggression among normal albumin values
using Fisher Exact & 𝑃 value (>0.05) and also along seven
weeks of follow up among cases.
Soliday et al. [8]a substantial percentage of children with
SSNS require a long-term (alternate day) steroid treatment,
that is, over many months and years. Thus, the key question
arises: which determinants are correlated with long-term
treatment and potential behavioral changes? Are these
(i) illness-related variables, for example, the number of
relapses,thecumulativesteroiddoseandsteroiddep-
endency, or
(ii) Factorsdeterminedbythe“familyclimate”asassessed
bystandardizedtests,forexample,thefamilyrelation-
ship index or the brief symptom record? [8].
As a minimum we should warn parents at the beginning
ofacourseofsteroidtherapythattheirchildmightexperience
behavioral changes. There are many areas for potential fur-
therresearchinthisfield.Theassessmentofpatients’behavior
following cessation of steroid therapy may help to confirm
that findings of behavioral change are steroid related. The
reassessment of the same patients over several episodes of
relapse may explain the possibility of any sensitization effect
of multiple courses of Steroids. Finally, future research may
b ew a r r a n t e dt oa s s e s sw a y so fd i m i n i s h i n g .
6. Conclusion
w ec o n c l u d e dt h a ta l ls t u d i e dc h i l d r e nw i t hS S N So ft e n
experiencesignificantproblemswithanxiety,depression,and
increased aggression during high dose steroid therapy.
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